Using multiple digestion enzymes and an Orbitrap Fusion Lumos, they identified 13,728 proteins with 57 percent median sequence coverage in MCF-7 cells.
Researchers from the cancer center recently published reverse-phase protein array-based characterizations covering more than 700 cancer cell lines.
The funds will support development of the company's mammalian display antibody technology, which it says could aid applications including biopharma research.
The company said investors have agreed to purchase $5.6 million of common stock as well as warrants that, if exercised, could raise an additional $5.1 million.
Under the deal, the parties will provide Perthera's Precision Cancer Analysis molecular profiling service to Hope for Stomach Cancer patients free of charge.
In Science this week: intellectual property landscape of CRISPR genome editing, and more.
A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.
Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.
Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.